Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbin Ji

Showing results (191-200 of 214) with videos related to

Pageof 22
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2009
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapySamanthi A Perera, Danan Li, Takeshi Shimamura, et al.
National Science Review|August 15, 2022
Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasisYujuan Jin, Qiqi Zhao, Weikang Zhu, et al.
Nature Cell Biology|February 7, 2018
The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168Xiaoduo Xie, Hongli Hu, Xinyuan Tong, et al.
Nature Medicine|November 14, 2017
Enhancing the precision of genetic lineage tracing using dual recombinasesLingjuan He, Yan Li, Yi Li, et al.
Signal Transduction and Targeted Therapy|August 14, 2024
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activationTao Zhang, Zilu Pan, Jing Gao, et al.
Cell Reports|July 11, 2019
Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase InhibitorsYuetong Wang, Jian Zhang, Shengxiang Ren, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsHongbin Ji, Xiaojun Zhao, Yuki Yuza, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
EED Maintains the Small Cell Lung Cancer Neuroendocrine Phenotype and Drives Lung Cancer Histological TransformationYixiang Li, Yasmin N Laimon, Hyeonseo Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
ROS1 rearrangements define a unique molecular class of lung cancersKristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, et al.
Cancer Cell|July 7, 2007
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapyDanan Li, Takeshi Shimamura, Hongbin Ji, et al.
Pageof 22

Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2009
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapySamanthi A Perera, Danan Li, Takeshi Shimamura, et al.
National Science Review|August 15, 2022
Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasisYujuan Jin, Qiqi Zhao, Weikang Zhu, et al.
Nature Cell Biology|February 7, 2018
The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168Xiaoduo Xie, Hongli Hu, Xinyuan Tong, et al.
Nature Medicine|November 14, 2017
Enhancing the precision of genetic lineage tracing using dual recombinasesLingjuan He, Yan Li, Yi Li, et al.
Signal Transduction and Targeted Therapy|August 14, 2024
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activationTao Zhang, Zilu Pan, Jing Gao, et al.
Cell Reports|July 11, 2019
Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase InhibitorsYuetong Wang, Jian Zhang, Shengxiang Ren, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsHongbin Ji, Xiaojun Zhao, Yuki Yuza, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
EED Maintains the Small Cell Lung Cancer Neuroendocrine Phenotype and Drives Lung Cancer Histological TransformationYixiang Li, Yasmin N Laimon, Hyeonseo Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
ROS1 rearrangements define a unique molecular class of lung cancersKristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, et al.
Cancer Cell|July 7, 2007
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapyDanan Li, Takeshi Shimamura, Hongbin Ji, et al.
Pageof 22